In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
Ann Intern Med. 2020 Dec 15;173(12):JC71
Authors: Kelsey MD, Newby LK
Abstract
SOURCE CITATION: Hopewell JC, Offer A, Haynes R, et al. Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom. Eur Heart J. 2020;41:3336-42. 32702748.
PMID: 33316194 [PubMed - in process]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Kelsey MD, Newby LK Tags: Ann Intern Med Source Type: research
More News: Cardiology | Cholesterol | Heart | Internal Medicine | Simvastatin | Statin Therapy | Zocor